Neuro-Bio Ltd

Neuro-Bio is a biotechnology company developing novel therapeutics for neurodegenerative disorders such as Alzheimer’s.

[Neuro-Bio Ltd @NeuroBioLtd]

@AgingJrnl published Neuro-Bio's paper in collaboration with @Unilever on June 28, 2023, entitled, “A novel peptide ‘T14’ reflects age and photo-aging in human skin." Read the full study at https://t.co/inBxplAi7W.

[Aptamer Group @AptamerGroup]

@NeuroBioLtd It is very exciting to be a part of this collaboration and we are looking forward to working with such an innovative partner.

[Xenopat @Xenopat_]

This week we had the chance to leave our comfort zone and learn about Alzheimer disease. All thanks to @NeuroBioLtd and the wonderful speakers that were there to celebrate @NeuroBioLtd 10th birthday. @accio_cat @MSCActions made this collaboration possible through TecnioSping.

[Neuro-Bio Ltd @NeuroBioLtd]

Thank you for being part of our panel discussion and for your enthusiasm and insights with this research.

[Neus Falgàs @NeusFalgas]

It’s been a pleasure to discuss Alzheimer’s Disease diagnostic/therapeutic approaches at the Royal College of Physicians @hospitalclinic and share a lovely time with old and new friends from @Xenopat_ 😉 @RBoqueSastre

[Neuro-Bio Ltd @NeuroBioLtd]

Thank you for joining us on this special occasion and for your continued support!

[Raquel Boque-Sastre @RBoqueSastre]

Grateful for the House of Lords invitation by @baroness_susan to the fantastic party celebrating @NeuroBioLtd's 10th anniversary. Thanks to Tecniospring Industry @accio_cat @MSCActions for enabling our collab. Pleasure sharing journey with my colleagues at @Xenopat_& @NeusFalgas

[Neuro-Bio Ltd @NeuroBioLtd]

We are delighted with this innovative collaboration and the advanced prospects this brings for an important cause!

[Aptamer Group @AptamerGroup]

Today we announce our partnership with @NeuroBioLtd to use #Optimer binders to develop a #diagnostic test for #Alzheimer's disease. Binders to a novel biomarker for the disease have been successfully developed and patented for use in a #lateralflow test.

https://t.co/1JiodvPcVe

[Neuro-Bio Ltd @NeuroBioLtd]

Finally out! 🎙️

The first episode of the podcast has been launched. If you want to know more about us and our project tap on the link in bio.

#neurobio #neuroscience #T14 #alzheimers #podcast #friday #clotavarde https://t.co/w5KJHk1ybC

[Neuro-Bio Ltd @NeuroBioLtd]

Have you read our latest paper?

Check it out on our website.
Link in our bio! 🧪

#alzheimers #T14 #toxin #antibody #receptor #neuroscience #2023 #elsevier #neurobio en Culham Science Centre https://t.co/7U5rQkM6JD

[Neuro-Bio Ltd @NeuroBioLtd]

Because knowing who and what you follow is important, here we present you our values.

#neurobio #alzheimers #values #biotech #science #T14 #neuroscience en Culham Science Centre https://t.co/CGbVZsKoyg

[Neuro-Bio Ltd @NeuroBioLtd]

"Critics say there is little conclusive evidence that removing amyloid plaques slows the development of Alzheimer’s..."

https://t.co/gohmXlrJSV

@FT @alzassociation

#alzheimers #research #treatment

[Baroness Susan Greenfield @baroness_susan]

US imposes strict curbs on contentious #Biogen #Alzheimers treatment

"Our approach has always been different to that of Biogen's... I hope we now receive more attention!"
- Baroness Susan Greenfield, CEO of @NeuroBioLtd

#research #alzheimersdisease

https://t.co/46sRuO0y5Z

[Baroness Susan Greenfield @baroness_susan]

Novel #drug from Neuro-Bio effective in a mouse model of #Alzheimers disease...

https://t.co/Bl6yAgdLFB

[Neuro-Bio Ltd @NeuroBioLtd]

Our new #drug shows promise for treating #neurodegeneration in a mouse model of #Alzheimers disease.
Results validate a process driving the #disease discovered & gradually characterised by @baroness_susan and team over 20 years.

https://t.co/DVt0WoWImK

@alzassociation

[Neuro-Bio Ltd @NeuroBioLtd]

Once again, a big thank you from us all!

[Dr. Abi George Yates @abigeorgeyates1]

Always happy to help regardless, but especially when I receive flowers as a thank you! 😍 what a surprise to come to work today and find these, thank you @NeuroBioLtd

[Baroness Susan Greenfield @baroness_susan]

It's been a joy working with NIVEA where they combine important science, based on the neurophysiology & psychology of touch with consume products...
#CareForHumanTouch
https://t.co/WjYtHh7IJE

[Neuro-Bio Ltd @NeuroBioLtd]

We are excited to announce that our CEO, Susan Greenfield will be visiting Tel Aviv and speaking at the BIRAX UK-Israel Health Aging Conference in November.

Visit: https://t.co/coaBrBOmAg to register your interest.

[Neuro-Bio Ltd @NeuroBioLtd]

Neuro-Bio welcomes Imogen Treger!
Having just finished her third year studying biochemistry at Oxford Uni, Imogen is very interested in exploring biotech as a career. She has joined as intern and is very excited to work with the team, to explore their research in more detail.

[Neuro-Bio Ltd @NeuroBioLtd]

Neuro-Bio welcomes Ruth Perera!
Having finished her A-Levels in Biology, Chemistry, Physics & French, Ruth has now joined as an intern to gain valuable laboratory experience. She feels being part of a solid team with a novel approach to Alzheimer’s Disease will be truly inspiring

[Neuro-Bio Ltd @NeuroBioLtd]

Neuro-Bio welcomes Lana Stewart!
Lana has joined as an intern to gain valuable insight in working in a laboratory and to learn new techniques.
She has just finished her A-Levels and is hoping to study Neuroscience at Exeter University.

[Neuro-Bio Ltd @NeuroBioLtd]

Culham Science Centre supported this years International Women’s Day (8th March 2021) and the campaign theme #ChooseToChallenge2021

Neuro-Bio is proud to share with you our Operations Director, Sara Garcia-Rates’ story:

#IWD2021